Shares of Myomo plunged 42% in after-hours trading Monday after the maker of wearable medical robotics cut its 2025 revenue forecast and reported a bigger-than-expected loss in the second quarter (Q2) ...

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological ...

Myomo MYO is preparing to release its quarterly earnings on Monday, 2025-08-11. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect Myomo to report ...

Good day and welcome to Myomo's Second Quarter of 2024 Earnings Call. All participants are in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask ...

BURLINGTON, Mass.--(BUSINESS WIRE)-- Myomo, Inc. (MYO), a wearable medical robotics company that offers improved arm and hand function for individuals with upper-limb paralysis and neuromuscular ...

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological ...

Maxim Group analyst Anthony Vendetti has reiterated their bullish stance on MYO stock, giving a Buy rating yesterday. Anthony Vendetti has given his Buy rating due to a combination of factors related ...

Analyst Anthony Vendetti from Maxim Group reiterated a Buy rating on Myomo (MYO – Research Report) and keeping the price target at $6.00. Anthony Vendetti’s rating is based on several key performance ...

Myomo (NYSEAMERICAN:MYO – Get Free Report) had its target price boosted by investment analysts at Ascendiant Capital Markets from $9.00 to $11.00 in a report issued on Monday,Benzinga reports. The ...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb ...